Literature DB >> 23375873

Shared dysregulated pathways lead to Parkinson's disease and diabetes.

Jose A Santiago1, Judith A Potashkin.   

Abstract

Recent evidence indicates that Parkinson's disease and diabetes, both age-related chronic diseases, share remarkably similar dysregulated pathways. Exposure to environmental factors and genetic susceptibility play a role in the etiology and progression of both diseases. In light of recent findings, an intriguing hypothesis has emerged that suggests that mitochondrial dysfunction, endoplasmic reticulum stress, inflammation, and alterations in metabolism may lead to insulin resistance and, ultimately, to diabetes and/or neurodegeneration. In this article, we summarize the studies that have addressed the relationship between Parkinson's disease and diabetes and propose that disruptions in these shared molecular networks lead to both chronic diseases.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23375873     DOI: 10.1016/j.molmed.2013.01.002

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  71 in total

1.  Polypharmacy in Parkinson's disease: risks and benefits with little evidence.

Authors:  I Csoti; H Herbst; P Urban; D Woitalla; U Wüllner
Journal:  J Neural Transm (Vienna)       Date:  2019-06-20       Impact factor: 3.575

2.  Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson's disease.

Authors:  Jose A Santiago; Judith A Potashkin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

3.  Correlation of insulin resistance and motor function in spinal and bulbar muscular atrophy.

Authors:  Hideaki Nakatsuji; Amane Araki; Atsushi Hashizume; Yasuhiro Hijikata; Shinichiro Yamada; Tomonori Inagaki; Keisuke Suzuki; Haruhiko Banno; Noriaki Suga; Yohei Okada; Manabu Ohyama; Tohru Nakagawa; Ken Kishida; Tohru Funahashi; Iichiro Shimomura; Hideyuki Okano; Masahisa Katsuno; Gen Sobue
Journal:  J Neurol       Date:  2017-02-22       Impact factor: 4.849

4.  Repurposing GLP-1 Receptor Agonists for Parkinson's Disease: Current Evidence and Future Opportunities.

Authors:  Daniella Balduino Victorino; Mariana Nejm; Marcia Guimarães-Marques; Fulvio Alexandre Scorza; Carla Alessandra Scorza
Journal:  Pharmaceut Med       Date:  2021-01-07

5.  Understanding the links between cardiovascular disease and Parkinson's disease.

Authors:  Judy Potashkin; Xuemei Huang; Claudia Becker; Honglei Chen; Thomas Foltynie; Connie Marras
Journal:  Mov Disord       Date:  2019-09-04       Impact factor: 10.338

6.  Genome-wide gene-environment interaction analysis of pesticide exposure and risk of Parkinson's disease.

Authors:  Joanna M Biernacka; Sun Ju Chung; Sebastian M Armasu; Kari S Anderson; Christina M Lill; Lars Bertram; J E Ahlskog; Laura Brighina; Roberta Frigerio; Demetrius M Maraganore
Journal:  Parkinsonism Relat Disord       Date:  2016-08-03       Impact factor: 4.891

7.  Plasma Metabolomic Markers of Insulin Resistance and Diabetes and Rate of Incident Parkinson's Disease.

Authors:  Samantha Molsberry; Kjetil Bjornevik; Katherine C Hughes; Zhongli Joel Zhang; Sarah Jeanfavre; Clary Clish; Brian Healy; Michael Schwarzschild; Alberto Ascherio
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

Review 8.  Diabetes Mellitus as a Risk Factor for Parkinson's Disease: a Molecular Point of View.

Authors:  Alice Biosa; Tiago F Outeiro; Luigi Bubacco; Marco Bisaglia
Journal:  Mol Neurobiol       Date:  2018-03-28       Impact factor: 5.590

9.  Reply to Liu et al.: HNF4A and PTBP1 expression in the brain of neurodegenerative disease patients.

Authors:  Jose A Santiago; Judith A Potashkin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-29       Impact factor: 11.205

Review 10.  Mitochondria, OxPhos, and neurodegeneration: cells are not just running out of gas.

Authors:  Estela Area-Gomez; Cristina Guardia-Laguarta; Eric A Schon; Serge Przedborski
Journal:  J Clin Invest       Date:  2019-01-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.